Jefferies Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-409,400
Closed -$40.7M 3284
2019
Q3
$40.7M Sell
409,400
-641,500
-61% -$61M 0.32% 37
2019
Q2
$97.1M Sell
1,050,900
-1,913,900
-65% -$182M 0.71% 11
2019
Q1
$280M Buy
2,964,800
+2,561,300
+635% +$224M 2.3% 6
2018
Q4
$25.9M Sell
403,500
-294,000
-42% -$21.7M 0.21% 68
2018
Q3
$62.4M Sell
697,500
-14,800
-2% -$1.31M 0.41% 27
2018
Q2
$56.6M Buy
712,300
+705,900
+11,030% +$58.6M 0.32% 36
2018
Q1
$571K Sell
6,400
-91,300
-93% -$8.76M ﹤0.01% 1433
2017
Q4
$10.2M Buy
97,700
+75,700
+344% +$8.54M 0.05% 303
2017
Q3
$3.21M Buy
22,000
+9,900
+82% +$1.35M 0.02% 711
2017
Q2
$1.57M Sell
12,100
-4,900
-29% -$600K 0.01% 1068
2017
Q1
$2.12M Sell
17,000
-18,900
-53% -$2.26M 0.02% 878
2016
Q4
$4.16M Sell
35,900
-27,900
-44% -$3.11M 0.02% 643
2016
Q3
$6.67M Buy
63,800
+56,900
+825% +$6.16M 0.03% 430
2016
Q2
$681K Sell
6,900
-99,600
-94% -$10.3M ﹤0.01% 1299
2016
Q1
$10.7M Sell
106,500
-317,800
-75% -$32.7M 0.06% 246
2015
Q4
$50.8M Buy
424,300
+244,500
+136% +$28.3M 0.29% 58
2015
Q3
$19.4M Buy
179,800
+106,700
+146% +$13.2M 0.11% 144
2015
Q2
$8.46M Sell
73,100
-8,700
-11% -$995K 0.04% 344
2015
Q1
$9.43M Buy
81,800
+19,800
+32% +$2.37M 0.05% 254
2014
Q4
$6.93M Buy
+62,000
New +$6.54M 0.04% 336
2013
Q3
Sell
-100,000
Closed -$5.85M 2462
2013
Q2
$5.85M Buy
+100,000
New +$6.02M 0.06% 223

Other funds holding CELG

Jefferies Group's CELG Position: Q4 2019 in Review

Jefferies Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 577,965 shares — an estimated $57.4M sold.

Jefferies Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $57.4M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Jefferies Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 577,965 Celgene Corp shares in Q4 2019, an estimated $57.4M.
  • Jefferies Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Jefferies Group's Celgene Corp position peaked at $57.4M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.